Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD

Detalhes bibliográficos
Autor(a) principal: Ribeiro, Ana R.
Data de Publicação: 2012
Outros Autores: Castro, P. M. L., Afonso, Carlos, Tiritan, Maria
Idioma: eng
Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Texto Completo: http://hdl.handle.net/10400.14/13238
Resumo: Biodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1.
id RCAP_a27d8244dd146351ad155a7f84ea6d36
oai_identifier_str oai:repositorio.ucp.pt:10400.14/13238
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FDbiodegradationchiralpharmaceuticalsBiodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1.VeritatiRibeiro, Ana R.Castro, P. M. L.Afonso, CarlosTiritan, Maria2013-11-14T15:40:31Z2012-032012-03-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.14/13238enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-13T12:47:12Zoai:repositorio.ucp.pt:10400.14/13238Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:51:44.281250Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
title Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
spellingShingle Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
Ribeiro, Ana R.
biodegradation
chiral
pharmaceuticals
title_short Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
title_full Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
title_fullStr Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
title_full_unstemmed Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
title_sort Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
author Ribeiro, Ana R.
author_facet Ribeiro, Ana R.
Castro, P. M. L.
Afonso, Carlos
Tiritan, Maria
author_role author
author2 Castro, P. M. L.
Afonso, Carlos
Tiritan, Maria
author2_role author
author
author
dc.contributor.none.fl_str_mv Veritati
dc.contributor.author.fl_str_mv Ribeiro, Ana R.
Castro, P. M. L.
Afonso, Carlos
Tiritan, Maria
dc.subject.por.fl_str_mv biodegradation
chiral
pharmaceuticals
topic biodegradation
chiral
pharmaceuticals
description Biodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1.
publishDate 2012
dc.date.none.fl_str_mv 2012-03
2012-03-01T00:00:00Z
2013-11-14T15:40:31Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/13238
url http://hdl.handle.net/10400.14/13238
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833601147326169088